Cargando…
Renal and Vascular Mechanisms of Thiazolidinedione-Induced Fluid Retention
Thiazolidinediones (TZDs) are peroxisome proliferator-activated receptor subtype γ (PPARγ) activators that are clinically used as an insulin sensitizer for glycemic control in patients with type 2 diabetes. Additionally, TZDs exhibit novel anti-inflammatory, antioxidant, and antiproliferative proper...
Autores principales: | Yang, Tianxin, Soodvilai, Sunhapas |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2531205/ https://www.ncbi.nlm.nih.gov/pubmed/18784848 http://dx.doi.org/10.1155/2008/943614 |
Ejemplares similares
-
Thiazolidinedione-Induced Fluid Retention: Recent Insights into the Molecular Mechanisms
por: Bełtowski, Jerzy, et al.
Publicado: (2013) -
Thiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium Retention
por: Horita, Shoko, et al.
Publicado: (2015) -
Farnesoid X Receptor Activation Stimulates Organic Cations Transport in Human Renal Proximal Tubular Cells
por: Wongwan, Teerasak, et al.
Publicado: (2020) -
Panduratin A Derivative Protects against Cisplatin-Induced Apoptosis of Renal Proximal Tubular Cells and Kidney Injury in Mice
por: Thongnuanjan, Penjai, et al.
Publicado: (2021) -
Novel Potential Application of Chitosan Oligosaccharide for Attenuation of Renal Cyst Growth in the Treatment of Polycystic Kidney Disease
por: Pathomthongtaweechai, Nutthapoom, et al.
Publicado: (2020)